Rock Springs Capital Management LP Mersana Therapeutics, Inc. Transaction History
Rock Springs Capital Management LP
- $2.94 Billion
- Q3 2024
A detailed history of Rock Springs Capital Management LP transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 3,046,782 shares of MRSN stock, worth $4.94 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
3,046,782
Previous 3,046,782
-0.0%
Holding current value
$4.94 Million
Previous $6.12 Million
5.98%
% of portfolio
0.2%
Previous 0.19%
Shares
18 transactions
Others Institutions Holding MRSN
# of Institutions
121Shares Held
116MCall Options Held
233KPut Options Held
457K-
Eco R1 Capital, LLC San Francisco, CA19.4MShares$31.4 Million1.59% of portfolio
-
Nextech Invest Ag12.1MShares$19.5 Million3.72% of portfolio
-
Vr Adviser, LLC New York, NY11.3MShares$18.4 Million2.22% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$14 Million2.94% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$13.6 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $157M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...